logo
Select company
Select metric
59.36%Gross Profits to Assets
VS
Market
92
Sector
90
Industry
94
History
85
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information

Ticker

YMAB

Company Name

Y-MABS THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Y-MABS THERAPEUTICS INC - Gross Profits to Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

YMAB - GPA Historical data
DateTotal AssetsGross ProfitGross Profits to Assets
6/30/2025$ 117.21M$ 69.58M59.36%
3/31/2025$ 112.61M$ 72.55M64.43%
12/31/2024$ 119.9M$ 72.43M60.41%
9/30/2024$ 120.92M$ 75.11M62.11%
6/30/2024$ 144.03M$ 76.7M53.25%
3/31/2024$ 123.31M$ 73.02M59.21%
12/31/2023$ 127.87M$ 73.4M57.4%
9/30/2023$ 128.88M$ 81.51M63.24%
6/30/2023$ 132.4M$ 73.76M55.71%
3/31/2023$ 137.44M$ 67.21M48.9%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • Y-MABS THERAPEUTICS INC's latest trailing twelve months (TTM) GPA stands at 0%.
  • Over the past 5 years, Y-MABS THERAPEUTICS INC's average GPA has been 37.95%.
  • The median GPA for Y-MABS THERAPEUTICS INC during this period was 44.85%
  • Y-MABS THERAPEUTICS INC reached its highest GPA over the past 5 years at 64.43%.
  • The lowest GPA recorded by Y-MABS THERAPEUTICS INC in the same timeframe 0%

Y-MABS THERAPEUTICS INC's GPA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

GPA Benchmarks
CompanyGPA
ADCT : ADC THERAPEUTICS SA 22.43%NKTR : NEKTAR THERAPEUTICS 30.13%KURA : KURA ONCOLOGY INC 12.2%LXRX : LEXICON PHARMACEUTICALS INC 25.69%TRDA : ENTRADA THERAPEUTICS INC 17.71%XOMA : XOMA ROYALTY CORP 20.12%SAGE : SAGE THERAPEUTICS INC 14.91%CDXS : CODEXIS INC 32.09%ARCT : ARCTURUS THERAPEUTICS HOLDINGS INC 39.49%SGMO : SANGAMO THERAPEUTICS INC 83.75%

Definition of Gross Profits to Assets

[Calculation] Gross Profits to Assets (GPA) measures how effective a company leverages its assets to generate gross profits. It is calculated as gross profits [GP] divided by [Assets].
GP / Assets
(=) GPA
GPA for Y-MABS THERAPEUTICS INC is calculated as follows: GP [ $ 0 ] / Assets [ $ 143.19M ]
(=) GPA [ 0% ]

YMAB - Gross Profits to Assets, Last 5 years

0%

Minimum

Sep 30, 2020

64.43%

Maximum

Mar 31, 2025

37.95%

Average

44.85%

Median

GPA Benchmark Analysis

The chart above depicts the distribution of GPA for companies in the Total Stock Market. The average GPA of the companies is 20.16% with a standard deviation of 19.95%.
The following table provides additional summary stats:
GPA in the Market:
filtered constituents4.13K
min-50.32%
max83.98%
average20.16%
median15.35%
std19.95%